
Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers
3 contributors - Paperback
£141.99
Dr. Ankit Jain is currently working as a Postdoctoral Research Associate at Texas A&M University School of Pharmacy, Texas. He completed his B. Pharm. (2006-09), M. Pharm. (Pharmaceutics, 2009-11), and Ph.D. (2012-17). Dr. Jain has been exploring different vesicular carriers viz. liposomes, niosomes, and micelles for the last eleven years. He has earmarked an appreciation for his outstanding performance in academics. He has been conferred with the “MP Young Scientist Award- 2017. He has published 60 International publications in journals of high repute (Citations = 2500+, h-index = 21, and I10-index = 55) along with 25 book chapters in International Books. He is a reviewer and editorial board member of different renowned journals of international publishers An overarching goal of his current research is the development of nano-engineered drug delivery systems for various diseases with a prime focus on cancer Dr. Nishi Mody is presently working as a Guest Lecturer in the Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar (M.P). She possesses a Gold Medal in B. Pharm. and M. Pharm and was awarded DST-INSPIRE for her Ph.D. She has a good number of publications (22) published in peer-reviewed International Journals with high impact factors (Biotechnology Advances, Nanomedicine, etc.) and many book chapters (23) in international books. She has been awarded many prestigious awards including M.P. Young Scientist Award-2020, the Pharmaceutical Science Alumni Award consecutively for two years (2007 and 2008), Prof. C. S. Chauhan Gold Medal (2009), IDMA J.B. Mody Award (2009) and Nagarjuna Award (2011) for her excellent academic performance in U.G. and P.G. programs... Her area of research is focused on nanofabrications of polymeric and vesicular systems for cancer treatment with recent advances in the state-of-art of her domain Prof. Srinath Palakurthi is a Professor at Irma Lerma Rangel School of Pharmacy at Texas A&M University, Kingsville, Texas. He has a strong background in drug delivery and pharmacokinetics with expertise in particulate and vesicular carrier systems for targeted drug and gene delivery applications. His research group has been working on different targeted drug delivery systems for cancer with a focus on combination therapy. He is the recipient of many prestigious awards including President’s Excellence Research Fund, Texas A& M University (2018), Academic Research Fellow, American Association of Colleges of Pharmacy (AACP) (2015), Governor’s 2010 Initiative (2005-2010), Research Centres Program, SD (2010), Governor’s 2010 Individual Research Seed Grant, SD (2005). Professor Palakurthi has a good number of publications in journals of high international repute.